Abstract
The prostate gland is the site of the second most common cancer in men in the UK, with 9,280 deaths recorded in 2000. Another common disease of the prostate is benign prostatic hyperplasia and both conditions are believed to arise as a result of changes in the balance between cell proliferation and differentiation. There are three types of prostatic epithelial cell, proliferative basal, secretory luminal, and neuroendocrine. All three are believed to be derived from a common stem cell through differentiation along different pathways but the mechanisms behind these processes is poorly understood. In particular, there has until recently been very little information about prostate stem cell growth and differentiation. This review will discuss ways of distinguishing these prostate cell types using markers, such as keratins. Methods available for the culture of prostate epithelial cells and for the characterisation of stem cells both in monolayer and three-dimensional models are examined.
Similar content being viewed by others
References
Abrahamsson P (1999) Neuroendocrine differentiation in prostatic carcinoma. The Prostate 39: 135–148.
Aumuller G, Leonhardt M, Janssen M, Konrad L, Bjartell A & Abrahamsson PA (1999) Neurogenic origin of human prostate endocrine cells. Urology 53: 1041–8.
Aumuller G, Leonhardt M, Renneberg H, von Rahden B, Bjartell A & Abrahamsson PA (2001) Semiquantative morphology of human prostatic development and regional distribution of prostatic neuroendocrine cells. The Prostate 46: 108–115.
Barrandon Y & Green H (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302–6.
Bayne CW, Ross M & Donnelly F et al. (1998) Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype. Urol Int 61: 1–7.
Bhatt RI, Hart C, Collins A, Ramani VAC, George NJR & Clarke NW (2002) A novel method for the isolation and evaluation of prostatic stem cells. Prostate Cancer and Prostatic Diseases: BPG Sept 2001 Meeting abstracts 5: 78.
Bonkhoff H & Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98–106.
Bonkhoff H, Stein U & Remberger K (1994) Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25: 42–6.
Bonkhoff H, Stein U & Remberger K (1994) The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24: 114–8.
Bonkhoff H (1996) Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur Urol 30: 201–5.
Collins AT, Habib FK, Maitland NJ & Neal DE (2001) Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 114: 3865–72.
Cunha GR, Donjacour AA & Cooke PS et al. (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338–62.
Fong CJ, Sherwood ER & Sutkowski DM et al. (1991) Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells. Prostate 19: 221–35.
Fry PM, Hudson DL, O'Hare MJ & Masters JR (2000) Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro. BJU Int 85: 504–13.
Hudson DL, Guy AT, Fry PM, O'HareMJ, Watt FM & Masters JRW (2001) Epithelial differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J.Histochem. Cytochem 49: 271–278.
Hudson DL, O'Hare MJ, Watt FM & Masters JRW (2000) Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest 80: 1243–1250.
Isaacs JT & Coffey DS (1989) Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2: 33–50.
Jones PH, Harper S & Watt FM (1995) Stem cell patterning and fate in human epidermis. Cell 80: 83–93.
Jones PH & Watt FM (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73: 713–24.
Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggcason K & Martin GR (1982) Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochem 23: 6188–6193.
Lang SH, Stark M, Collins A, Paul AB, Stower MJ & Maitland NJ (2001) Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ. 12: 631–640.
Lechner JF, Babcock MS, Marnell M, Narayan KS & Kaighn ME (1980) Normal human prostate epithelial cell cultures. Methods Cell Biol: 195–225.
Liu AY, True LD & LaTray L et al. (1999) Analysis and sorting of prostate cancer cell types by flow cytometry. Prostate 40: 192–9.
Moll R, FrankeWW, Schiller DL, Geiger B & Krepler R (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11–24.
Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA & Celniker A (1987) Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 47: 281–286.
Peehl DM & Stamey TA (1986) Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 22: 82–90.
Peehl DM, Wong ST, Stamey TA (1988) Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 24: 530–6.
Potten CS & Loeffler M (1990) Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110: 1001–20.
Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM & Lane EB (1990) Antibody markers of basal cells in complex epithelia. J Cell Sci 97(Pt 1): 39–50.
Reya T, Morrison SJ, Clarke MF & Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105–111.
Richardson GD, Robson CN, Neal DE & Collins AT (2002) AC133: a putative marker of prostate epithelial stem cells. Prostate Cancer and Prostatic Diseases: BPG Sept 2001 Meeting abstracts 5: 77.
Robinson EJ, Neal DE & Collins AT (1998) Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37: 149–60.
Rumpold H, Heinrich E & Untergasser G et al. (2002) Neuroendocrine differentiation of human prostatic primary epithelial cell in vitro. The Prostate 53: 101–108.
Stasiak PC, Purkis PE, Leigh IM & Lane EB (1989) Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 92: 707–16.
van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D & Schalken J (2000) Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest 80: 1251–8.
van Leenders GJ & Schalken JA (2001) Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis. BJU int 88: 35–42.
Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM & Schalken JA (1992) Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 52: 6182–7.
Xue Y, Smedts F, Debruyne FMJ, de la Rosette JJ & Schalken JA (1998) Identification of intermediate cell types by keratin expression in the developing prostate. Prostate 34: 292–301.
Xue Y, Verhofstad A & Lange W et al. (1997) Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate. Am J Pathol 151: 1759–65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hudson, D.L. Prostate epithelial stem cell culture. Cytotechnology 41, 189–196 (2003). https://doi.org/10.1023/A:1024887009081
Issue Date:
DOI: https://doi.org/10.1023/A:1024887009081